Zealand Pharma A/S
GIP agonist compounds and methods
Last updated:
Abstract:
The present invention relates to acylated GIP analogues which have GIP agonist activity, and their use in the treatment of metabolic disorders.
Status:
Grant
Type:
Utility
Filling date:
21 Feb 2019
Issue date:
11 May 2021